Sudeep Pharma

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0QPI01025
  • NSEID: SUDEEPPHRM
  • BSEID: 544619
INR
1,192.30
-20.55 (-1.69%)
BSENSE

Nov 20

BSE+NSE Vol: 1.27 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Sep'26
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Net Sales
196.70
158.27
182.34
172.34
162.67
124.92
157.55
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
196.70
158.27
182.34
172.34
162.67
124.92
157.55
Raw Material Cost
71.37
68.81
71.14
70.26
70.48
57.63
63.38
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
-1.86
-12.21
-7.28
-10.07
-9.54
-15.31
-3.61
Employee Cost
15.61
14.34
10.52
15.04
14.10
12.24
10.94
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
-0.01
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
38.34
32.43
45.37
37.14
32.17
26.48
28.06
Total Expenditure (Excl Depreciation)
123.46
103.36
119.75
112.37
107.21
81.04
98.77
Operating Profit (PBDIT) excl Other Income
73.24
54.91
62.59
59.97
55.46
43.88
58.78
Other Income
5.98
5.45
6.42
6.84
10.17
5.16
3.76
Operating Profit (PBDIT)
79.22
60.36
69.01
66.81
65.63
49.04
62.54
Interest
2.81
2.06
2.44
1.17
2.28
1.71
1.85
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
76.41
58.30
66.57
65.64
63.35
47.33
60.69
Depreciation
5.38
4.00
3.88
3.86
3.81
3.25
2.83
Profit Before Tax
71.03
54.29
62.69
61.78
59.53
44.07
57.85
Tax
19.22
13.71
14.15
14.08
12.76
12.80
13.67
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
51.81
40.59
48.54
47.70
46.78
31.27
44.19
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
51.81
40.59
48.54
47.70
46.78
31.27
44.19
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.36
0.04
-0.34
0.24
1.03
0.46
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
51.45
40.55
48.88
47.46
45.75
30.81
44.19
Equity Capital
11.29
11.29
11.29
11.29
9.72
9.72
9.72
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
4.56
3.59
4.33
4.2
4.71
3.17
4.55
Diluted Earnings per share
4.59
3.59
4.38
4.29
4.2
2.84
4.07
Operating Profit Margin (Excl OI)
37.23%
34.69%
34.33%
34.8%
34.09%
35.13%
37.31%
Gross Profit Margin
38.85%
36.84%
36.51%
38.09%
38.94%
37.89%
38.52%
PAT Margin
26.34%
25.65%
26.62%
27.68%
28.76%
25.03%
28.05%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Sep 2026 is 24.28% vs -13.20% in Jun 2026

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Sep 2026 is 26.88% vs -17.04% in Jun 2026

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2026 is 33.38% vs -12.27% in Jun 2026

stock-summary

Interest

QoQ Growth in quarter ended Sep 2026 is 36.41% vs -15.57% in Jun 2026

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2026 has improved from Jun 2026

Compare Quarterly Results Of Sudeep Pharma With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
196.70
441.17
-244.47
-55.41%
Other Operating Income
0.00
0.00
0.00
Total Operating income
196.70
441.17
-244.47
-55.41%
Raw Material Cost
71.37
35.01
36.36
103.86%
Purchase of Finished goods
0.00
68.24
-68.24
-100.00%
(Increase) / Decrease In Stocks
-1.86
-22.74
20.88
91.82%
Employee Cost
15.61
124.24
-108.63
-87.44%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
38.34
140.47
-102.13
-72.71%
Total Expenditure (Excl Depreciation)
123.46
345.22
-221.76
-64.24%
Operating Profit (PBDIT) excl Other Income
73.24
95.95
-22.71
-23.67%
Other Income
5.98
2.48
3.50
141.13%
Operating Profit (PBDIT)
79.22
98.43
-19.21
-19.52%
Interest
2.81
2.75
0.06
2.18%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
76.41
95.68
-19.27
-20.14%
Depreciation
5.38
15.06
-9.68
-64.28%
Profit Before Tax
71.03
80.75
-9.72
-12.04%
Tax
19.22
20.44
-1.22
-5.97%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
51.81
60.18
-8.37
-13.91%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
51.81
60.18
-8.37
-13.91%
Share in Profit of Associates
0.00
0.13
-0.13
-100.00%
Minority Interest
0.36
0.00
0.36
Other related items
0.00
0.00
0.00
Consolidated Net Profit
51.45
60.31
-8.86
-14.69%
Equity Capital
11.29
61.16
-49.87
-81.54%
Face Value
1.00
10.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
4.56
9.86
-5.30
-53.75%
Diluted Earnings per share
4.59
9.86
-5.27
-53.45%
Operating Profit Margin (Excl OI)
37.23%
21.75%
0.00
15.48%
Gross Profit Margin
38.85%
21.69%
0.00
17.16%
PAT Margin
26.34%
13.67%
0.00
12.67%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 196.70 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 24.28% vs -13.20% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 20.92% vs 9.32% in Sep 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 51.45 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 26.88% vs -17.04% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 12.46% vs -6.15% in Sep 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 73.24 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 33.38% vs -12.27% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 32.06% vs -12.62% in Sep 2025

Quarterly - Interest
Interest 2.81 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 36.41% vs -15.57% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 23.25% vs 117.14% in Sep 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 37.23%
in Sep 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2026 has improved from Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 has improved from Sep 2025